Atomo Diagnostics Ltd
ASX:AT1

Watchlist Manager
Atomo Diagnostics Ltd Logo
Atomo Diagnostics Ltd
ASX:AT1
Watchlist
Price: 0.021 AUD 5% Market Closed
Market Cap: 14.4m AUD

Relative Value

The Relative Value of one AT1 stock under the Base Case scenario is 0.016 AUD. Compared to the current market price of 0.021 AUD, Atomo Diagnostics Ltd is Overvalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AT1 Relative Value
Base Case
0.016 AUD
Overvaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
93
vs Industry
40
Median 3Y
3.2
Median 5Y
5
Industry
2.3
vs History
vs Industry
Median 3Y
-2
Median 5Y
-3.4
Industry
22
vs History
vs Industry
Median 3Y
-3
Median 5Y
-10.4
Industry
14.3
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-6
Industry
20
vs History
76
vs Industry
50
Median 3Y
1.4
Median 5Y
1.6
Industry
2.2
vs History
92
vs Industry
48
Median 3Y
2.3
Median 5Y
3
Industry
2.4
vs History
93
vs Industry
43
Median 3Y
5.5
Median 5Y
9.2
Industry
5
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-2.7
Industry
11.6
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-2.7
Industry
15.9
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-7
Industry
14.3
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-4.1
Industry
18
vs History
82
vs Industry
45
Median 3Y
1.5
Median 5Y
1.7
Industry
1.8

Multiples Across Competitors

AT1 Competitors Multiples
Atomo Diagnostics Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Atomo Diagnostics Ltd
ASX:AT1
13.4m AUD 3.1 -2.1 -1.9 -1.9
US
Abbott Laboratories
NYSE:ABT
208.7B USD 4.9 15.5 20.1 28.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
185B USD 21.2 74.7 60.2 73.2
US
Boston Scientific Corp
NYSE:BSX
154.8B USD 8.8 76.1 35.9 49.9
US
Stryker Corp
NYSE:SYK
148.6B USD 6.4 52 25.7 30.9
IE
Medtronic PLC
NYSE:MDT
114.8B USD 3.4 24.6 13.7 19.6
DE
Siemens Healthineers AG
XETRA:SHL
52.3B EUR 2.3 25 14 19.5
US
Becton Dickinson and Co
NYSE:BDX
51.8B USD 2.5 34.1 13.5 25.2
US
Edwards Lifesciences Corp
NYSE:EW
44.8B USD 8.1 10.7 24.5 27
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.9B USD 10.7 46.8 33.2 37.1
US
Resmed Inc
NYSE:RMD
37.7B USD 7.5 28.7 20.5 23.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Atomo Diagnostics Ltd
ASX:AT1
Average EV/EBITDA: 26.1
Negative Multiple: -1.9
N/A N/A
US
Abbott Laboratories
NYSE:ABT
20.1
13%
1.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
60.2
24%
2.5
US
Boston Scientific Corp
NYSE:BSX
35.9
21%
1.7
US
Stryker Corp
NYSE:SYK
25.7
12%
2.1
IE
Medtronic PLC
NYSE:MDT
13.7
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
14
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.5
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
24.5
12%
2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
33.2
12%
2.8
US
Resmed Inc
NYSE:RMD
20.5
12%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Atomo Diagnostics Ltd
ASX:AT1
Average EV/EBIT: 33.5
Negative Multiple: -1.9
N/A N/A
US
Abbott Laboratories
NYSE:ABT
28.9
22%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
73.2
26%
2.8
US
Boston Scientific Corp
NYSE:BSX
49.9
31%
1.6
US
Stryker Corp
NYSE:SYK
30.9
16%
1.9
IE
Medtronic PLC
NYSE:MDT
19.6
15%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.5
19%
1
US
Becton Dickinson and Co
NYSE:BDX
25.2
28%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
27
12%
2.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.1
12%
3.1
US
Resmed Inc
NYSE:RMD
23.2
14%
1.7